Polycystic Ovary Syndrome and NC-CAH: Distinct Characteristics and Common Findings. A Systematic Review

    June 2019 in “ Frontiers in Endocrinology
    Georgios Papadakis, Eleni Kandaraki, Ermioni Tseniklidi, Olga Papalou, Evanthia Diamanti-Kandarakis
    Image of study
    TLDR Polycystic Ovary Syndrome (PCOS) is common in women with conditions like anovulation, hirsutism, hair loss, and type 2 diabetes, and it can lead to health risks like heart disease, obesity, insulin resistance, and depression. Non-Classic Congenital Adrenal Hyperplasia (NC-CAH) is also discussed.
    The 2019 systematic review discussed the distinct characteristics and common findings of Polycystic Ovary Syndrome (PCOS) and Non-Classic Congenital Adrenal Hyperplasia (NC-CAH). It highlighted the prevalence of PCOS in women with conditions such as anovulation, idiopathic hirsutism, androgenic alopecia, and type 2 diabetes mellitus, and the increased frequency of PCOS in women with a history of gestational diabetes due to metabolic and steroidogenic alterations. The review also explored the health risks associated with PCOS, including cardiovascular risk, obesity, insulin resistance, and depressive disorders, and the dermatologic manifestations of PCOS, including hirsutism. Additionally, it discussed the clinical and molecular characterization of women with NC-CAH. The document did not specify the number of participants in the study.
    Discuss this study in the Community →

    Research cited in this study

    15 / 15 results

    Related Community Posts Join

    6 / 12 results

      community How does hair loss and recovery work?

      in Chat  12 upvotes 2 months ago
      Hair loss varies due to genetic sensitivity to DHT and other factors. Treatments discussed include finasteride, minoxidil, RU58841, and microneedling.

      community C’est terrible - at my wits end

      in Female  445 upvotes 1 year ago
      A 29-year-old woman is experiencing gradual hair thinning since age 15, suspects Androgenic Alopecia, and has tried 5% minoxidil with little success. She has purchased various hair loss treatments including minoxidil, dutasteride, finasteride, and spironolactone, but is cautious about starting them due to potential interactions with her ADHD medication.

      community Female, 30, PCOS diagnosis, MPB Norwood 2. Endo refuses to give anything other than Spironolactone. Feel like I’m at my wit’s end here.

      in Female  56 upvotes 1 year ago
      A 30-year-old female with PCOS and male pattern baldness is frustrated with her endocrinologist's recommendation of only Spironolactone and minoxidil, feeling that dutasteride, finasteride, and progesterone would be more effective. Other users suggest various online sources for treatments, warn against self-medicating due to potential risks, and recommend seeking a specialized endocrinologist or considering additional treatments like Inositol, Berberine, and dermaneedling.

      community Why balding gets worse in every generation?

      in Chat  81 upvotes 5 months ago
      Balding seems to worsen with each generation, possibly due to stress, diet, and environmental factors. The user started treatments like Minoxidil and finasteride.

    Related Research

    1 / 1 results